Relationship Between IL-33/ST2 Signal Pathway and Inflammatory Bowel Disease / 胃肠病学

ABSTRACT

Interleukin-33 (IL-33), a novel identified member of IL-1 superfamily, is involved in the development and progress of various immune-related diseases, including inflammatory bowel disease (IBD), via its receptor ST2-mediated pathway, but the mechanism is not fully clarified. It has been reported that IL-33 plays a dual role in promoting inflammation and inducing protective effect in intestinal mucosa. This article reviewed the relationship between IL-33/ST2 signal pathway and IBD.